(Q36760093)

English

AIDS in pregnancy, part II: Treatment in the era of highly active antiretroviral therapy and management of obstetric, anesthetic, and pediatric issues

scientific article published on March 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

1 reference

Europe PubMed Central

AIDS in pregnancy, part II: Treatment in the era of highly active antiretroviral therapy and management of obstetric, anesthetic, and pediatric issues (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

author name string

Dimitris Rigopoulos

1

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Stamatis Gregoriou

2

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Vasilis Paparizos

3

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Andreas Katsambas

4

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

publication date

1 March 2007

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

79-84

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2007.05927.X

21 January 2018

Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2007.05927.X

21 January 2018

Twenty-four month efficacy of a maternal short-course zidovudine regimen to prevent mother-to-child transmission of HIV-1 in West Africa

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2007.05927.X

21 January 2018

Timing of the maternal drug dose and risk of perinatal HIV transmission in the setting of intrapartum and neonatal single-dose nevirapine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2007.05927.X

21 January 2018

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2007.05927.X

21 January 2018

Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2007.05927.X

21 January 2018

Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2007.05927.X

21 January 2018

A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2007.05927.X

21 January 2018

Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2007.05927.X

21 January 2018

Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2007.05927.X

21 January 2018

Increased risk of adverse pregnancy outcomes in HIV-infected women treated with highly active antiretroviral therapy in Europe

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2007.05927.X

21 January 2018

Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2007.05927.X

21 January 2018

HIV-1 genotypic zidovudine drug resistance and the risk of maternal--infant transmission in the women and infants transmission study. The Women and Infants Transmission Study Group.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2007.05927.X

21 January 2018

Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2007.05927.X

21 January 2018

Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2007.05927.X

21 January 2018

Emergence of antiretroviral resistance in HIV-positive women receiving combination antiretroviral therapy in pregnancy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2007.05927.X

21 January 2018

Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2007.05927.X

21 January 2018

Antiretroviral therapy during pregnancy and the risk of an adverse outcome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2007.05927.X

21 January 2018

Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2007.05927.X

21 January 2018

The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2007.05927.X

21 January 2018

Perinatal HIV-1 transmission: interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2007.05927.X

21 January 2018

Mothers infected with HIV.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2007.05927.X

21 January 2018

Retrospective follow-up of maternal deaths and their associated risk factors in a rural district of Tanzania

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2007.05927.X

21 January 2018

The effect of pregnancy in HIV-infected women

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2007.05927.X

21 January 2018

Human immunodeficiency virus: anesthetic and obstetric considerations.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2007.05927.X

21 January 2018

Ritonavir's role in reducing fentanyl clearance and prolonging its half-life.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2007.05927.X

21 January 2018

Anesthesia and the HIV infected parturient: a retrospective study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2007.05927.X

21 January 2018

Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2007.05927.X

21 January 2018

HIV-1 infection in children: a clinical and immunologic overview

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2007.05927.X

21 January 2018

Morbidity and mortality during the first two years of life among uninfected children born to human immunodeficiency virus type 1-infected women: the women and infants transmission study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2007.05927.X

21 January 2018

Longitudinal analysis of human immunodeficiency virus type 1 RNA in breast milk and of its relationship to infant infection and maternal disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1540-9740.2007.05927.X

21 January 2018

Identifiers

10.1111/J.1540-9740.2007.05927.X

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36760093&oldid=1655415696"